• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向树突状细胞的转录来耐受激活的致病性 CD4+T 细胞。

Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells.

机构信息

Institute of Virology, University of Zürich, Zürich, Switzerland.

出版信息

Gene Ther. 2015 May;22(5):382-90. doi: 10.1038/gt.2015.6. Epub 2015 Mar 5.

DOI:10.1038/gt.2015.6
PMID:25739989
Abstract

We have recently shown that targeted expression of myelin oligodendrocyte glycoprotein (MOG) to dendritic cells with self-inactivating-lentivirus vectors induces antigen-specific tolerance in naive antigen-specific CD4+ T cells and protects mice from experimental autoimmune encephalomyelitis (EAE). In the present study, we demonstrate that this approach also induces tolerance of activated antigen-specific CD4+ T cells and completely protects mice from passive EAE induction. Tolerance induction did not correlate with the depletion of the preactivated antigen-specific CD4+ T cells. However, upon isolation and in vitro re-stimulation at day 6 after adoptive transfer the MOG-specific CD4+ T cells from the non-tolerized mice produced large amounts of inflammatory cytokines, whereas those from tolerized mice did not. This unresponsiveness correlated with the upregulation of regulatory molecules associated with anergy and regulatory T cells (Tregs). The in vivo depletion of Tregs resulted in EAE susceptibility of the tolerized animals, suggesting that these cells have indeed a role in tolerance induction/maintenance.

摘要

我们最近的研究表明,利用自我失活慢病毒载体靶向表达髓鞘少突胶质细胞糖蛋白(MOG)至树突状细胞,可诱导幼稚抗原特异性 CD4+T 细胞产生抗原特异性耐受,并保护小鼠免受实验性自身免疫性脑脊髓炎(EAE)的影响。在本研究中,我们证明了该方法也可诱导活化的抗原特异性 CD4+T 细胞耐受,并完全保护小鼠免受被动 EAE 的诱导。耐受诱导与预先激活的抗原特异性 CD4+T 细胞的耗竭无关。然而,在过继转移后第 6 天分离和体外再刺激时,非耐受小鼠来源的 MOG 特异性 CD4+T 细胞产生大量的炎症细胞因子,而耐受小鼠来源的细胞则没有。这种无反应性与与失能和调节性 T 细胞(Tregs)相关的调节分子的上调相关。体内耗尽 Tregs 会导致耐受动物出现 EAE 易感性,这表明这些细胞在诱导和维持耐受中确实发挥作用。

相似文献

1
Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells.通过靶向树突状细胞的转录来耐受激活的致病性 CD4+T 细胞。
Gene Ther. 2015 May;22(5):382-90. doi: 10.1038/gt.2015.6. Epub 2015 Mar 5.
2
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.用不完全弗氏佐剂预先免疫神经抗原的小鼠 T 细胞耗竭脾细胞可预防实验性自身免疫性脑脊髓炎。
Immunol Lett. 2014 Jan-Feb;157(1-2):38-44. doi: 10.1016/j.imlet.2013.11.001. Epub 2013 Nov 9.
3
Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.甘露糖缀合的髓磷脂肽可激活非致病性Th1和Th17细胞,并改善实验性自身免疫性脑脊髓炎。
Exp Neurol. 2015 May;267:254-67. doi: 10.1016/j.expneurol.2014.10.019. Epub 2014 Oct 30.
4
Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.在粒细胞-巨噬细胞集落刺激因子(GM-CSF)缺陷的Csf2-/-小鼠中,CD4+ CD25+调节性T细胞的耗竭会使其易患实验性自身免疫性脑脊髓炎(EAE)。
J Leukoc Biol. 2016 Oct;100(4):747-760. doi: 10.1189/jlb.3A0815-359R. Epub 2016 Jun 2.
5
Selective depletion of CD11c CD11b dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.选择性清除CD11c CD11b树突状细胞可部分消除静脉注射髓鞘少突胶质细胞糖蛋白在小鼠实验性自身免疫性脑脊髓炎中的致耐受性作用。
Eur J Immunol. 2016 Oct;46(10):2454-2466. doi: 10.1002/eji.201546274.
6
Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.通过转移表达髓鞘少突胶质细胞糖蛋白肽以及肿瘤坏死因子相关凋亡诱导配体(TRAIL)或程序性死亡-1配体的胚胎干细胞衍生树突状细胞预防实验性自身免疫性脑脊髓炎
J Immunol. 2005 Feb 15;174(4):1888-97. doi: 10.4049/jimmunol.174.4.1888.
7
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.髓鞘少突胶质细胞糖蛋白在小鼠中诱导对髓鞘和神经元自身抗原均具有特异性的CD4(+) T细胞产生不完全耐受。
Eur J Immunol. 2016 Sep;46(9):2247-59. doi: 10.1002/eji.201646416. Epub 2016 Jul 21.
8
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.琥珀酰亚胺基-4-[N-马来酰亚胺甲基]环己烷-1-羧酸酯连接的髓鞘少突胶质糖蛋白 35-55 耦联脾细胞输注可有效预防和逆转实验性自身免疫性脑脊髓炎。
J Immunol Res. 2015;2015:129682. doi: 10.1155/2015/129682. Epub 2015 Jul 14.
9
Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice.骨髓表达自身抗原的非清髓性移植可建立外周耐受,并完全预防小鼠的自身免疫。
Gene Ther. 2012 Nov;19(11):1075-84. doi: 10.1038/gt.2011.179. Epub 2011 Nov 10.
10
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.半乳糖凝集素-1对于在实验性自身免疫性脑脊髓炎中诱导基于髓鞘少突胶质细胞糖蛋白35-55的静脉内耐受至关重要。
Eur J Immunol. 2016 Jul;46(7):1783-96. doi: 10.1002/eji.201546212. Epub 2016 May 25.

引用本文的文献

1
An engineered Fc fusion protein that targets antigen-specific T cells and autoantibodies mitigates autoimmune disease.一种工程化的 Fc 融合蛋白,可靶向针对抗原的 T 细胞和自身抗体,从而减轻自身免疫性疾病。
J Neuroinflammation. 2023 Dec 6;20(1):291. doi: 10.1186/s12974-023-02974-9.
2
Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future.多发性硬化症的抗原特异性治疗模式:过去、现在和未来。
Front Immunol. 2021 Feb 19;12:624685. doi: 10.3389/fimmu.2021.624685. eCollection 2021.
3
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis.

本文引用的文献

1
Functional relevance for multiple sclerosis-associated genetic variants.与多发性硬化症相关的基因变异的功能相关性。
Immunogenetics. 2015 Jan;67(1):7-14. doi: 10.1007/s00251-014-0803-4. Epub 2014 Oct 12.
2
Update on disease-modifying treatments for multiple sclerosis.多发性硬化症疾病修正治疗的最新进展。
Clin Ther. 2014 Dec 1;36(12):1938-1945. doi: 10.1016/j.clinthera.2014.08.006. Epub 2014 Sep 15.
3
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.针对进展性多发性硬化症的爱泼斯坦-巴尔病毒特异性过继性免疫疗法。
免疫重建疗法:多发性硬化症持久缓解的概念。
Nat Rev Neurol. 2020 Jan;16(1):56-62. doi: 10.1038/s41582-019-0268-z. Epub 2019 Oct 24.
4
Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.短期雷帕霉素治疗可使免疫原性基因工程骨髓在低剂量照射下实现植入,从而实现长期免疫耐受。
Stem Cell Res Ther. 2017 Mar 9;8(1):57. doi: 10.1186/s13287-017-0508-3.
Mult Scler. 2014 Oct;20(11):1541-4. doi: 10.1177/1352458514521888. Epub 2014 Feb 3.
4
Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis.调节性T细胞在多发性硬化症病毒模型中的保护和有害作用。
Brain Pathol. 2014 Sep;24(5):436-51. doi: 10.1111/bpa.12119. Epub 2014 Feb 25.
5
Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.自体髓鞘肽耦联细胞诱导的抗原特异性耐受:多发性硬化的 1 期临床试验。
Sci Transl Med. 2013 Jun 5;5(188):188ra75. doi: 10.1126/scitranslmed.3006168.
6
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.靶向 B 细胞治疗多发性硬化症:最新进展与尚存挑战。
Ther Adv Neurol Disord. 2013 May;6(3):161-73. doi: 10.1177/1756285612474333.
7
Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.凋亡细胞处理的树突状细胞静脉输注通过阻断 Th17 细胞活性诱导免疫耐受。
Immunobiology. 2013 Aug;218(8):1069-76. doi: 10.1016/j.imbio.2013.02.003. Epub 2013 Mar 1.
8
Association of smoking with risk of multiple sclerosis: a population-based study.吸烟与多发性硬化症风险的关联:一项基于人群的研究。
J Neurol. 2013 Jul;260(7):1778-81. doi: 10.1007/s00415-013-6873-7. Epub 2013 Mar 2.
9
Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells.通过上调抑制性的 IL-10(+) IFN-γ(+) 产生 CD4(+) T 细胞的数量,诱导静脉内转移未成熟树突状细胞的免疫耐受。
Immunol Res. 2013 May;56(1):1-8. doi: 10.1007/s12026-012-8382-7.
10
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.多发性硬化症:细胞因子在发病机制及治疗中的作用
Int J Mol Sci. 2012 Oct 19;13(10):13438-60. doi: 10.3390/ijms131013438.